Receptor model for the molecular basis of tissue selectivity of 1,4-dihydropyridine calcium channel drugs
- 1 September 1990
- journal article
- conference paper
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 4 (3) , 215-230
- https://doi.org/10.1007/bf00125011
Abstract
Our analysis of the solid state conformations of nifedipine [dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinecarboxylate] and its 1,4-dihydropyridine (1,4-DHP) analogues produced a cartoon description of the important interactions between these drugs and their voltage-dependent calcium channel receptor. In the present study a molecular-level detailed model of the 1,4-DHP receptor binding site has been built from the published amino acid sequence of the 215-1 subunit of the voltage-dependent calcium channel isolated from rabbit skeletal muscle transverse tubule membranes. The voltage-sensing component of the channel described in this work differs from others reported for the homologous sodium channel in that it incorporates a water structure and a staggered, rather than eclipsed, hydrogen bonded S4 helix conformation. The major recognition surfaces of the receptor lie in helical grooves on the S4 or voltagesensing α-helix that is positioned in the center of the bundle of transmembrane helices that define each of the four calcium channel domains. Multiple binding clefts defined by Arg-X-X-Arg-P-X-X-S ‘reading frames’ exist on the S4 strand. The tissue selectivity of nifedipine and its analogues may arise, in part, from conservative changes in the amino acid residues at the P and S positions of the reading frame that define the ester-binding regions of receptors from different tissues. The crystal structures of two tissue-selective nifedipine analogues, nimodipine [isopropyl (2-methoxyethyl) 1,4-dihydro-2,6- dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylate] and nitrendipine [ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylate] are reported. Nimodipine was observed to have an unusual ester side chain conformation that enhances the fit to the proposed ester-sensing region of the receptor.This publication has 29 references indexed in Scilit:
- The Photosynthetic Reaction Center from the Purple Bacterium Rhodopseudomonas viridisScience, 1989
- Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) seriesJournal of Medicinal Chemistry, 1988
- Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11-dicarboxylates as calcium entry antagonists: new conformationally restrained analogs of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformationJournal of Medicinal Chemistry, 1987
- Data Reduction and Error Analysis for Accurate Single Crystal Diffraction IntensitiesCrystallography Reviews, 1987
- Comparison Between X‐Ray Crystallographic Data and Physicochemical Parameters with Respect to Their Information about the Calcium Channel Antagonist Activity of 4‐Phenyl‐1,4‐dihydropyridinesQuantitative Structure-Activity Relationships, 1986
- The structure of the voltage‐sensitive sodium channelFEBS Letters, 1985
- Crystal Structure of the Calcium Channel Antagonist: 3,5-Bis(methoxycarbonyl)-2,6-dimethyl-4-(2-trifluoromethylphenyl)-1,4-dihydropyridine.Acta Chemica Scandinavica, 1985
- 2-Cyano-1-methyl-3-{2-[(5-methyl-1H-imidazol-4-yl)methylthio]-ethyl}guanidine monohydrateActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1980
- Diethyl 2,6-dimethyl-4-phenyl-1,4-dihydro-3,5-pyridinedicarboxylateActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1978
- 2,6-Dimethyl-3,5-diacetyl-4-(β-pyridyl)-1,4-dihydropyridineActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1977